Search

Displaying results 5581 - 5590 of 10000 in total
  1. Drug

    Abicipar Pegol

    go.drugbank.com/drugs/DB12258
    Investigational

    Abicipar Pegol has been used in trials studying the treatment of Macular Edema and Macular Degeneration.

  2. Drug

    Evodenoson

    go.drugbank.com/drugs/DB12295
    Investigational

    Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension.

  3. Drug

    Perzinfotel

    go.drugbank.com/drugs/DB12365
    Investigational

    Perzinfotel has been used in trials studying the treatment of Diabetes Mellitus and Diabetic Neuropathy, Painful.

  4. Drug

    OSI-027

    go.drugbank.com/drugs/DB12387
    Investigational

    OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.

  5. Drug

    BI-671800

    go.drugbank.com/drugs/DB12524
    Investigational

    Bi 671800 has been used in trials studying the treatment of Asthma and Rhinitis, Allergic, Perennial.

  6. Drug

    MK-0686

    go.drugbank.com/drugs/DB12563
    Investigational

    MK0686 has been used in trials studying the treatment of Osteoarthritis, Pain, Postoperative, and Neuralgia, Postherpetic.

  7. Drug

    Senrebotase

    go.drugbank.com/drugs/DB12626
    Investigational

    Senrebotase has been used in trials studying the treatment of Neuralgia, Postherpetic and Urinary Bladder, Overactive.

  8. Drug

    Neflamapimod

    go.drugbank.com/drugs/DB07138
    Investigational

    Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive Impairment.

  9. Drug

    Hyperforin

    go.drugbank.com/drugs/DB01892
    InvestigationalNutraceutical

    One of the most important members of this family, due to its medical properties, is _Hypericum perforatum_, also known as St John's wort.

  10. Drug

    IMM-101

    go.drugbank.com/drugs/DB15850
    Investigational

    As of July 2020, researchers from the Ottawa Hospital and Queen’s University, in partnership with the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG), are conducting a trial in over … It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma[A220013,A220018,A220023].